Key facts
- This page summarizes John E. Davis's Form 4 filing for ARTIVION, INC. (AORT).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 12 Mar 2025, 15:32.
John E. Davis - 11 Mar 2025 Form 4 Insider Report for ARTIVION, INC. (AORT)
- Reporting relationship
- Chief Commercial Officer
- Issuer ticker
- AORT
- Reported as of
- 11 Mar 2025
- Net transaction value
- -$13,688
- SEC form
- 4
- Accepted by SEC
- 12 Mar 2025, 15:32:23 UTC
- Prior SEC filing
- 10 Mar 2025
- Next SEC filing
- 14 Aug 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ John E. Davis
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
John E. Davis filed Form 4 for ARTIVION, INC. (AORT) on 12 Mar 2025.
Change
- Previous filing in this sequence was filed on 10 Mar 2025.
- Current net transaction value: -$13,688.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AORT
transaction
Common Stock
Options Exercise
- Transaction value
- $342,860
- Shares
- +15,910
- Change %
- +7.7%
- Price
- $21.55
- Shares after
- 223,878
- Date
- 11 Mar 2025
- Ownership
- Direct
- Footnotes
- F1
AORT
transaction
Common Stock
Sale
- Transaction value
- $356,549
- Shares
- -15,100
- Change %
- -6.7%
- Price
- $23.61
- Shares after
- 208,778
- Date
- 11 Mar 2025
- Ownership
- Direct
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
AORT
transaction
Derivative
Stock Options (Right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -15,910
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 11 Mar 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 15,910
- Exercise price
- $21.55
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 3 footnotes
Footnote F1
The sale reported on this form was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on August 30, 2024.
Footnote F2
Reflects weighted average price. Range of prices were between $23.14 to $23.89. The reporting person will provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Footnote F3
Stock option vests 33 1/3% per year beginning on the first anniversary of the grant date. The first exercisable date was March 12, 2019.